Bioquímica y Biología Molecular

2023

1. Actionable wastewater surveillance: application to a university residence hall during the transition between Delta and Omicron resurgences of COVID-19

   Frontiers in Public Health, Vol. 11

2. Acyl coenzyme A binding protein (ACBP): An aging- and disease-relevant “autophagy checkpoint”

   Aging Cell, Vol. 22, Núm. 9

3. Alternative strategies to the use of glycosylated hemoglobin in monitoring the glycemic status of diabetic patients with end-stage renal disease

   Medicina Clinica, Vol. 160, Núm. 4, pp. 145-150

4. Analysis of ATG4C function in vivo

   Autophagy, Vol. 19, Núm. 11, pp. 2912-2933

5. Apoptotic cell death in disease—Current understanding of the NCCD 2023

   Cell Death and Differentiation, Vol. 30, Núm. 5, pp. 1097-1154

6. Assessment of coagulation assays on Roche Cobas t711 analyzer: Performance and clinical implications

   Blood Coagulation and Fibrinolysis, Vol. 34, Núm. 8, pp. 523-529

7. Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes (Nature Biotechnology, (2020), 38, 3, (288-292), 10.1038/s41587-019-0360-3)

   Nature Biotechnology

8. Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing (Nature Genetics, (2020), 52, 3, (331-341), 10.1038/s41588-019-0576-7)

   Nature Genetics

9. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x)

   Nature Genetics

10. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x)

    Nature Genetics

11. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (Nature Genetics, (2020), 52, 3, (294-305), 10.1038/s41588-019-0564-y)

    Nature Genetics

12. Author Correction: Genomic basis for RNA alterations in cancer (Nature, (2020), 578, 7793, (129-136), 10.1038/s41586-020-1970-0)

    Nature

13. Author Correction: Multiparameter prediction of myeloid neoplasia risk (Nature Genetics, (2023), 55, 9, (1523-1530), 10.1038/s41588-023-01472-1)

    Nature Genetics

14. Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6)

    Nature

15. Author Correction: Patterns of somatic structural variation in human cancer genomes (Nature, (2020), 578, 7793, (112-121), 10.1038/s41586-019-1913-9)

    Nature

16. Author Correction: The evolutionary history of 2,658 cancers (Nature, (2020), 578, 7793, (122-128), 10.1038/s41586-019-1907-7)

    Nature

17. Author Correction: The landscape of viral associations in human cancers (Nature Genetics, (2020), 52, 3, (320-330), 10.1038/s41588-019-0558-9)

    Nature Genetics

18. Author Correction: The repertoire of mutational signatures in human cancer (Nature, (2020), 578, 7793, (94-101), 10.1038/s41586-020-1943-3)

    Nature

19. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

    Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539

20. Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

    Molecular Cancer, Vol. 22, Núm. 1